Pregnant women: Safety of betahistine mesilate during pregnancy has not been reported. This drug should be administered to pregnant patients or women suspected of being pregnant, only if the expected therapeutic benefit is thought to outweigh any possible risk.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
